Autologous Superficial Femoral Vein for Aortic Reconstruction in Infected Fields

Brown, Philip M.; Kim, Victor B.; Lalikos, Janice F.; Deaton, David N.; Bogey, William M.; Powell, Charles S.

doi:10.1007/s100169900217

Cited by 38 publications

(17 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Autogenous femoral vein has been used in situ in 17 infected aortofemoral bypasses with "reasonable patient survival and limb salvage" [14].…”

Section: Treatmentmentioning

confidence: 99%

New Alternatives in Management of the Infected Vascular Prosthesis

Wilson

2001

Surgical Infections

View full text Add to dashboard Cite

Advances in the management of infected vascular prostheses over the last decade have led to improved mortality and decreased amputation rates with conventional excision and extraanatomical bypass. Newer methods including in situ graft replacement with antibiotic-impregnated prosthetics appear suitable for low-virulence S. epidermidis infection. Early results are promising for cryopreserved allografts and autogenous femoral vein in situ grafts; however, more clinical experience and longer follow-up will be needed to confirm their durability in a contaminated field.

show abstract

“…Autogenous femoral vein has been used in situ in 17 infected aortofemoral bypasses with "reasonable patient survival and limb salvage" [14].…”

Section: Treatmentmentioning

confidence: 99%

New Alternatives in Management of the Infected Vascular Prosthesis

Wilson

2001

Surgical Infections

View full text Add to dashboard Cite

show abstract

“…One of the biggest assets is that graft infection has not been reported until now. 11 Repair of the mycotic abdominal aortic aneurysm in our patient with the SFV seemed to be an appropriate choice as, at autopsy, this part of the reconstructed aorta did not show degenerative or infectious changes 2 years after surgery. After the resection of the SFV from the right In 1998, the use of stent grafts for the treatment of thoracic mycotic aortic aneurysms was introduced by Semba and colleagues.…”

Section: Discussionmentioning

confidence: 85%

Conventional or Endovascular Treatment of Ongoing Mycotic Aortic Aneurysmal Disease?

et al. 2009

View full text Add to dashboard Cite

We report a case in which conventional and endovascular exclusion techniques were used to treat ongoing mycotic aortic aneurysmal disease. A 51-year-old man presented with an infrarenal mycotic aortic aneurysm that was excluded and reconstructed with a superficial femoral vein. Two years later, he developed a symptomatic mycotic aneurysm of the descending thoracic aorta, which required emergent treatment with a stent graft. The patient died 5 months later of massive bleeding owing to an aortobronchial fistula deriving from a new thoracic aneurysm proximal to the stent graft. Choices and different modes of treatment are discussed. Endovascular treatment of symptomatic mycotic aortic aneurysm might provide a valid alternative to open repair but may be unsuccessful owing to ongoing infection. In situ replacement using autologous material seems appealing whenever feasible.

show abstract

“…14-17 Also, ruptured infected abdominal aneurysms can be repaired by using autologous superficial vein grafts. 15,17 However, there are several limitations in in situ aortoiliofemoral reconstruction using autologous femoral veins in terms of surgical procedures (long harvesting time; size discrepancy between aorta and graft) and postoperative results (limb swelling; graft occlusion due to valve-related thrombosis). 18 Arterial homografts have been used as an alternative to prosthetic grafts for in-situ graft repair especially for patients with infected prosthetic grafts 8,10-12 or infected aortic aneurysms.…”

Section: Discussionmentioning

confidence: 99%

In situ replacement with equine pericardial roll grafts for ruptured infected aneurysms of the abdominal aorta

Yamamoto

Ishibashi

Motokawa

2009

Journal of Vascular Surgery

View full text Add to dashboard Cite

We describe surgical in situ replacement using an equine pericardial roll to treat ruptured infected abdominal aortic aneurysms (AAA) in two patients. A 78-year-old man diagnosed with ruptured infected (Bacteroides fragilis) AAA underwent in situ replacement of the abdominal aorta using a bifurcated equine pericardial roll graft with concomitant omentum flap wrapping. A 50-year-old man diagnosed with ruptured infected (Streptococcus agalactiae) AAA underwent the same procedure, except the graft was straight. Computed tomography of this patient revealed no graft dilation or surrounding fluid accumulation at 48 months after surgery. We therefore suggest that in situ replacement of the abdominal aorta using equine pericardium with concomitant omental flap wrapping may be an option of treating ruptured infected AAAs.

show abstract

Autologous Superficial Femoral Vein for Aortic Reconstruction in Infected Fields

Cited by 38 publications

References 11 publications

New Alternatives in Management of the Infected Vascular Prosthesis

New Alternatives in Management of the Infected Vascular Prosthesis

Conventional or Endovascular Treatment of Ongoing Mycotic Aortic Aneurysmal Disease?

In situ replacement with equine pericardial roll grafts for ruptured infected aneurysms of the abdominal aorta

Contact Info

Product

Resources

About